Rab31-dependent regulation of transforming growth factor ß expression in breast cancer cells

Susanne Soelch1, Nathalie Beaufort2, Daniela Loessner3,4

  • 1Clinical Research Unit, Department of Obstetrics and Gynecology, Technische Universität München, Ismaninger Str. 22, 81576, Munich, Germany.

Abstract

Insights

Rab31 overexpression in breast cancer cells significantly down-regulates TGF-ß1 expression and impacts TGF-ß signaling. This suggests Rab31 influences tumor invasion by modulating the TGF-ß pathway.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Rab31, a small GTP-binding protein, is implicated in tumor progression, including cell proliferation, adhesion, and invasion.
  • Rab31 is hypothesized to function as a molecular switch regulating the transition between proliferative and invasive cellular phenotypes.

Purpose of the Study:

  • To investigate the effect of Rab31 overexpression on gene expression related to epithelial-to-mesenchymal transition (EMT) in breast cancer cells.
  • To determine if Rab31 influences the expression of genes within the transforming growth factor beta (TGF-ß) signaling pathway.

Main Methods:

  • Differential gene expression analysis using PCR arrays in Rab31 high- and low-expressing breast cancer cell lines (CAMA-1, MDA-MB-231).
  • Validation of gene and protein expression using quantitative PCR (qPCR), ELISA, and Western blot.
  • Assessment of TGF-ß activity using a TGF-ß bioassay.

Main Results:

  • Rab31 overexpression led to significant down-regulation of TGFB1 (encoding TGF-ß1) by over 25-fold in CAMA-1 cells, also observed in MDA-MB-231 cells.
  • Reduced intracellular and secreted TGF-ß1 protein levels and decreased TGF-ß activity were detected in cells overexpressing Rab31.
  • Analysis of TGF-ß signaling pathway genes revealed significant down-regulation of 12 mRNAs and up-regulation of 7 mRNAs upon Rab31 overexpression.

Conclusions:

  • Rab31 acts as a significant modulator of TGF-ß1 expression in breast cancer.
  • Rab31 influences the TGF-ß signaling pathway, suggesting a role in regulating tumor cell invasion and metastasis.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
8.0K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.2K